3-D Tractography FUS Ablation for Essential Tremor
NCT: NCT06331052 · RECRUITING
Brief Summary
The investigators propose to advance Vim-FUSA (Ventral Intermediate Nucleus - Focused Ultrasound Ablation) with the support of 3-D tractography, a neuroimaging technique to visually represent nerve tracts within the brain. The investigators hypothesize that 3-D tractography Vim-FUSA will improve the Vim ablation compared to standard Vim-FUSA and prove safe and feasible in the clinical setting. The investigators also hypothesize that intraoperative magnetic resonance (i-MR) monitoring will differentiate ablated tissue from immediate perilesional edema and accurately predict the Vim-FUSA clinical outcomes.
Frequently Asked Questions
What is 3-D Tractography FUS Ablation for Essential Tremor?
3-D Tractography FUS Ablation for Essential Tremor is a clinical trial registered under NCT06331052. Current status: RECRUITING.
What is the status of NCT06331052?
The current status of NCT06331052 (3-D Tractography FUS Ablation for Essential Tremor) is: RECRUITING.
When did 3-D Tractography FUS Ablation for Essential Tremor start?
3-D Tractography FUS Ablation for Essential Tremor started on 2024-02-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.